Three consecutive pregnancies in a woman with Crigler-Najjar syndrome type II with good maternal and neonatal outcomes

Digestive and Liver Disease

Volumn 43, Issue 2, 2011, Pages 170-

  Holstein, Andreas ^a   Bryan, Corinna S ^a  

^a Lippe Detmold Clinic   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ARGININE; BILIRUBIN; GLYCINE; PHENOBARBITAL;

ADULT; AMINO ACID SUBSTITUTION; AMNIOCENTESIS; AUTOSOMAL RECESSIVE DISORDER; BILIRUBIN BLOOD LEVEL; CASE REPORT; CESAREAN SECTION; CHILD; CRIGLER NAJJAR SYNDROME; DIZZINESS; ECHOCARDIOGRAPHY; EMBRYO DEVELOPMENT; ENZYME ACTIVITY; FATIGUE; FEMALE; FETUS GROWTH; HUMAN; HYDRAMNIOS; HYPERBILIRUBINEMIA; INFANT; LETTER; LOW DRUG DOSE; MACROSOMIA; OUTCOME ASSESSMENT; PHOTOTHERAPY; PREGNANCY; PREGNANCY OUTCOME; PRESCHOOL CHILD; PRIORITY JOURNAL; SCHOOL CHILD;

ADULT; ANTICONVULSANTS; CESAREAN SECTION; CRIGLER-NAJJAR SYNDROME; FEMALE; HUMANS; INFANT, NEWBORN; PHENOBARBITAL; PHOTOTHERAPY; PREGNANCY; PREGNANCY COMPLICATIONS; PREGNANCY OUTCOME; TREATMENT OUTCOME;

EID: 78651464833     PISSN: 15908658     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.dld.2010.08.003     Document Type: Letter

References (5)

1. Tukey R.H., Strassburg C.P. Human UDP-glucuronosyltransferases: metabolism, expression, and disease. Annu. Rev. Pharmacol. Toxicol. 2000, 40:581-616.
2. Passuello V., Puhl A.G., Wirth S., et al. Pregnancy outcome in maternal Crigler-Najjar syndrome type II: a case report and review of the literature. Fetal Diagn. Ther. 2009, 26:121-126.
3. Arora N., Choudhary S. Pregnancy with Crigler-Najjar syndrome type II. J. Obstet. Gynaecol. 2009, 29:242-244.
4. Holstein A., Plaschke A., Lohse P., et al. Successful photo- and phenobarbital therapy during pregnancy in a woman with Crigler-Najjar syndrome type II. Scand. J. Gastroenterol. 2005, 40:1124-1126.
5. Ito T., Katagiri C., Ikeno S., et al. Phenobarbital following phototherapy for Crigler-Najjar syndrome type II with good fetal outcome: a case report. J. Obstet. Gynaecol. Res. 2001, 27:33-35.